Abstract

Cephalosporins are beta-lactam antibiotics that are widely used in China. Five generations of cephalosporins have been introduced in clinical practice to date; moreover, some new candidates are also undergoing clinical evaluations. To improve the success rates of new drug development, we need to have a comprehensive understanding about the relationship between the structure of cephalosporins and the toxicity that it induces at an early stage. In the cephalosporins toxicity study using zebrafish, the drug absorption is a key point. In this study, we determined the absorption of cephalosporins in zebrafish during toxicity test. The internal concentrations of 19 cephalosporins in zebrafish were determined using a developed liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Furthermore, a quantitative structure-activity relationship (QSAR) model was established by multilinear regression; moreover, it was used to predict the absorption of cephalosporins in zebrafish. During leave-one-out cross-validation, a satisfactory performance was obtained with a predictive ability (q2) of 0.839. The prediction ability of the model was further confirmed when the predictive ability (q2) was 0.859 in external prediction. The best QSAR model, which was based on five molecular descriptors, exhibited a promising predictive performance and robustness. In experiments involving drug toxicity, the developed QSAR model was used to estimate internal concentrations of cephalosporins. Thus, the toxicity results were correlated with the internal concentration of the drug within the larvae. The developed model served as a new powerful tool in zebrafish toxicity tests.

Highlights

  • Cephalosporins are one kind of potentβ-lactam antibiotics

  • Cephalosporins were derived from the core structure of 7-aminocephalosporanic acid (7-ACA), which attracted a lot of Predicting Cephalosporin Absorption in Zebrafish attention from chemists

  • We analyzed the internal concentrations of cephalosporins in zebrafish

Read more

Summary

Introduction

Cephalosporins are one kind of potentβ-lactam antibiotics. A cephalosporin was synthesized for the first time in 1964. The molecule 7-ACA had a unique structure, which could be modified to develop new antibiotic candidates; these new antibiotic candidates have to be clinically evaluated before being introduced into the market (Macheboeuf et al, 2007). To minimize the attrition rates of drug development, the toxicity of candidate drugs must be determined accurately. This is a crucial part of the drug discovery process. The success rate of new drug development is very low. To improve this parameter, we need to have a comprehensive understanding of the relationship between toxicity and drug structure

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.